Janney Capital analyst Ken Trbovich reiterated a Buy rating and $35 fair value target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Linden Disruption Expected to Have 'Minimal Impact' on Horizon Pharma (HZNP) - MizuhoNovember 11, 2015 11:57 AM FBR Analyst Comments on Skirmish Between Express Scripts (ESRX) and Horizon Pharma (HZNP)November 11, 2015 11:29 AM